SARS-CoV-2 testing remains an essential tool as we seek to restore the health of communities globally. In 40–45% of cases, infection with SARS-CoV-2 does not lead to symptomatic disease, and it is estimated that up to 50% of new infections originate from exposure to individuals without symptoms. Screening tests are intended to identify infected individuals who may be contagious, regardless of whether they are displaying symptoms, so that measures can be taken to prevent those individuals from infecting others. Thus, screening of asymptomatic persons is critical to reducing transmission and enabling a safe return to work, school, and community activities.
Download this whitepaper to discover a SARS-CoV-2 test that:
Technology Networks Limited
Woodview | Bull Lane Industrial Estate | Sudbury | C010 0FD | UK
Email: privacy@technologynetworks.com
© 2021 Technology Networks. All rights reserved
Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy